Diabetes Therapy

NovoMix 30 and FlexPen now available in the E.U.

Published in Diabetes Week, April 29th, 2002

Novo Nordisk A/S announced that NovoMix 30 FlexPen , the dual-release insulin analogue and pen system designed specifically for people starting insulin therapy, is now available in the Netherlands, Ireland, and the U.K.

NovoMix 30 is an insulin analogue combining 30% rapid-acting insulin aspart, and 70% intermediate-acting insulin aspart.

NovoMix 30 will be available in FlexPen , a new prefilled insulin pen designed to be simpler, easier, and more discreet to use than other prefilled pens.

"Our goal for the development of NovoMix 30 FlexPen was to find the best way to help people with diabetes start on insulin therapy simply and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Diabetes Week

Source: Diabetes Week (2002-04-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry